The Centers for Medicare and Medicaid Services released on Tuesday the list of 10 medications that will be part of the price-setting Drug Price Negotiation Program through the Inflation Reduction Act, affecting an estimated 8.2 million patients with a range of illnesses, including heart failure, blood clots, diabetes, and arthritis.
Washington Examiner: CMS names 10 drugs under new price controls, but advocates warn of 'cruel' side effects
Previous
Previous
Blog Post: Biden’s Drug List Moves America’s Patient Doomsday Clock Closer to Midnight
Next
Next